Dr. Pradeep Bhide, director of the Center for Brain Repair at Florida State University, together with Drs. Biederman and Spencer at Mass. General Hospital, are working on a non-stimulant for ADHD.Because those with ADHD have low dopamine levels, this new drug raises this level slowly and avoids the high and fear of addiction as well as the other side effects characterizing the stimulants.
According to Dr. Harold Levinson, if this new drug is successful in clinical trials it will be very long acting and relatively side-effect free. Although years from approval, it offers those with ADHD a greater probability for help in the future. And it will hopefully provide greater insights into other effective drugs. Unfortunately, the name of the drug was no doubt deliberately omitted.
About Harold Levinson, M.D.
Formerly Clinical Associate Professor of Psychiatry at New York University Medical Center, Dr. Harold Levinson is currently Director of the Levinson Medical Center for Learning Disabilities in Great Neck, Long Island, New York. He is a well known neuropsychiatrist, clinical researcher and author. His “highly original” research into the cerebellar-vestibular (inner-ear) origins and treatment of dyslexia and related learning, attention-deficit/hyperactivity and anxiety or phobic disorders has evolved over the past four decades. Initially supported by Nobel Laureate Sir John Eccles and other outstanding cerebellar neurophysiologists and inner-ear scientists, Levinson’s research has more recently been independently validated worldwide by highly sophisticated neuroimaging brain studies.
01/07/2014 4:34 pm http://news.fsu.edu/More-FSU-News/Non-addictive-ADHD-drug-on-horizon-at-Florida-State-University
Photo courtesy of Naypong/FreeDigitalPhotos.net